Atropine Sulfate Injection Shortage
Last Updated: September 16, 2025
Status: Current
Unavailable, Current:
- Atropine Sulfate, Injection, .05 mg/1 mL (Accord Healthcare Inc.)
- Atropine Sulfate, Injection, .1 mg/1 mL (Accord Healthcare Inc.)
- Atropine Sulfate, Injection, .4 mg/1 mL (Accord Healthcare Inc.)
- Atropine Sulfate, Injection, 0.5 mg/5 mL (0.1 mg/mL) Syringes (Hospira, Inc., a Pfizer Company)
Available, Current:
- Atropine Sulfate, Injection, .1 mg/1 mL (Amphastar Pharmaceuticals, Inc.)
- Atropine Sulfate, Injection, .1 mg/1 mL (Medefil, Inc.)
- Atropine Sulfate, Injection, .4 mg/1 mL (American Regent, Inc.)
- Atropine Sulfate, Injection, .4 mg/1 mL (Fresenius Kabi USA, LLC)
- Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (Hospira, Inc., a Pfizer Company)
- Atropine Sulfate, Injection, 0.4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
- Atropine Sulfate, Injection, 1 mg/1 mL (American Regent, Inc.)
- Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (Hospira, Inc., a Pfizer Company)
Unavailable., Current:
Unavailable, 90 days, Current:
- Atropine Sulfate, Injection, .4 mg/1 mL (Accord Healthcare Inc.)
- Atropine Sulfate, Injection, 0.1 mg/1 mL (Accord Healthcare Inc.)
- Atropine Sulfate, Injection, 1 mg/1 mL (Accord Healthcare Inc.)
To Be Discontinued:
Atropine Sulfate, Injection, .05 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-483-03Availability: Unavailable
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2020
Contact info: 866-941-7875, option 2
Atropine Sulfate, Injection, .1 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-484-90Availability: Unavailable
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2020
Contact info: 866-941-7875, option 2
Atropine Sulfate, Injection, .4 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-512-43Availability: Unavailable
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Reason for shortage: Requirements related to complying with good manufacturing practices
Related Information: Resupply TBD
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 866-941-7875, option 2
Atropine Sulfate, Injection, 0.5 mg/5 mL (0.1 mg/mL) Syringes (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-4910-34Availability: Unavailable
Status: Current
Date of update: August 19, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Next Delivery and Estimated Recovery: December 2028
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 844-646-4398
Related info link: https://dps.fda.gov/drugshortages/discontinuations/atropine-sulfate-injection
Atropine Sulfate, Injection, .1 mg/1 mL (Amphastar Pharmaceuticals, Inc.)
NDC Code: 76329-3340-1Availability: Available
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2020
Contact info: 800-423-4136
Atropine Sulfate, Injection, .1 mg/1 mL (Medefil, Inc.)
NDC Code: 64253-400-91Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 630-682-4600
Atropine Sulfate, Injection, .4 mg/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 63323-580-20Availability: Available
Status: Current
Date of update: September 2, 2025
Update type: Reverified
Related Information: Check wholesalers for inventory
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 888-386-1300
Atropine Sulfate, Injection, .4 mg/1 mL (American Regent, Inc.)
NDC Code: 0517-1004-25Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Related Information: old NDC 0517-0401-25
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 800-645-1706
Atropine Sulfate, Injection, .4 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-525-08Availability: Unavailable, 90 days
Status: Current
Date of update: August 19, 2025
Update type: Revised
Reason for shortage: Requirements related to complying with good manufacturing practices
Related Information: Manufacturing in process
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 866-941-7875, option 2
Atropine Sulfate, Injection, 0.1 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-484-45Availability: Unavailable, 90 days
Status: Current
Date of update: August 19, 2025
Update type: Revised
Reason for shortage: Requirements related to complying with good manufacturing practices
Related Information: Manufacturing in process
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2020
Contact info: 866-941-7875, option 2
Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-9630-05Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 844-646-4398
Atropine Sulfate, Injection, 0.4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
NDC Code: 0641-6251-10Availability: Available
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: December 20, 2023
Contact info: 800-631-2174
Atropine Sulfate, Injection, 1 mg/1 mL (American Regent, Inc.)
NDC Code: 0517-1001-25Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Related Information: old NDC 0517-1010-25
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 800-645-1706
Atropine Sulfate, Injection, 1 mg/1 mL (Accord Healthcare Inc.)
NDC Code: 16729-526-08Availability: Unavailable, 90 days
Status: Current
Date of update: August 19, 2025
Update type: Revised
Reason for shortage: Requirements related to complying with good manufacturing practices
Related Information: Manufacturing in process
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 866-941-7875, option 2
Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-1630-10Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 844-646-4398
Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-4911-34Availability: Unavailable.
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Next Delivery: January 2026; Estimated Recovery: March 2026
Therapeutic category: Anesthesia; Neurology; Pediatric
Initial posting date: January 1, 2012
Contact info: 844-646-4398
Atropine Sulfate, Injection, .1 mg/1 mL (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-4910-34Status: To Be Discontinued
Date of update: February 19, 2025
Update type: New
Therapeutic category: Anesthesia; Neurology; Pediatric
Date discontinued: February 19, 2025
Initial posting date: February 19, 2025
Contact info: 844-646-4398
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.